Q4 2023 Market Commentary
This is the season of forecasts. A bit like midges in the Scottish Highlands, they come around every year, and are about as much use.
This is the season of forecasts. A bit like midges in the Scottish Highlands, they come around every year, and are about as much use.
We are pleased to announce the establishment of a £20 million secured medium term note (“MTN”) programme for specialist property lender Lendco Limited (“Lendco”). Lendco …
We thought it might be interesting to address three current topics: structural issues in the equity markets, housing and artificial intelligence.
My colleagues and I were saddened to read of the death of Sir Win Bischoff on 25th April. He was an inspiration to the founders of LGB when they worked at Schroders.
During March, LGB investors were invited to participate in an EIS-qualifying IPO onto AIM for Ocean Harvest Technology plc (OHT), a UK based company which manufactures animal feed additives from seaweed blends.
During February, LGB investors were invited to participate in an EIS-qualifying private placing for Itaconix PLC (ITX), a New Hampshire based company listed on AIM.
What is the Enterprise Investment Scheme? Written by Megan Dempster, February 2023 The Enterprise Investment Scheme (EIS) was introduced by the government in 1994 to …
LGB & Co. Limited has acted as placing agent for the issuance of two and three year notes that have enabled Interrad Medical Inc. to raise $5.6 million. The company is well positioned to make subcutaneous securement of catheters the global standard of care in 2023.
We have seen sharp variations in the performance of shares of life sciences companies on AIM since our last update in June, and distortions make a few of our companies with strong investment cases worth another look..
These are difficult times for investors. The MSCI World Index has declined for four months and has given up its gains of the last year. …